FAM
DNTH icon

Fred Alger Management’s Dianthus Therapeutics DNTH Stock Holding History

Fred Alger Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.5M Buy
1,161,923
+1,128,463
+3,373% +$65.3M 0.43% 36
2025
Q4 		$1.38M Sell
33,460
-11,844
-26% -$459K 0.01% 338
2025
Q3 		$1.78M Buy
+45,304
New +$1.16M 0.01% 328
2024
Q4 		– Sell
-9,633
Closed -$264K – 425
2024
Q3 		$264K Buy
9,633
+3,316
+52% +$92.4K ﹤0.01% 396
2024
Q2 		$163K Sell
6,317
-30,050
-83% -$722K ﹤0.01% 393
2024
Q1 		$1.09M Sell
36,367
-4,474
-11% -$97.2K 0.01% 369
2023
Q4 		$425K Buy
+40,841
New +$451K ﹤0.01% 402
2021
Q2 		– Sell
-4,969
Closed -$941K – 518
2021
Q1 		$941K Buy
+4,969
New +$836K ﹤0.01% 392

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fred Alger Management's DNTH Position: Q1 2026 in Review

Fred Alger Management increased its Dianthus Therapeutics (DNTH) stake by 3,373% in Q1 2026, buying an estimated $65.3M and bringing the position to 1,161,923 shares worth $97.5M. The position accounts for 0.43% of the portfolio, ranked #36.

Fred Alger Management first reported a position in DNTH in Q1 2021 and has held it in 8 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Fred Alger Management held 1,161,923 shares of Dianthus Therapeutics worth $97.5M as of Q1 2026.
  • Fred Alger Management bought 1,128,463 Dianthus Therapeutics shares in Q1 2026, an estimated $65.3M.
  • Dianthus Therapeutics made up 0.43% of Fred Alger Management's portfolio in Q1 2026, its #36 holding.
  • Fred Alger Management first reported a position in Dianthus Therapeutics in Q1 2021 and has held it in 8 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.